Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹900 target, citing growth in specialised care and operational improvements.